Boston, MA 10/09/2014 (wallstreetpr) – Unilife Corp (NASDAQ:UNIS) shares continued their extended bull run at the markets on 8th October. The investor sentiment remained bullish in the stock after the injectable drugs delivery devices manufacturer announced earlier this week that it has entered into a strategic multiyear tie up with France based drug major Sanofi SA (ADR) (NYSE:SNY).
Unilife Corp (NASDAQ:UNIS) will be the exclusive supplier of “wearable injectors” of the drugs for 15 years as per the agreement. The agreement specifically excludes the insulin shots manufactured and sold by Sanofi SA (ADR) (NYSE:SNY). The terms of the agreement also keeps the option open for Unilife Corp (NASDAQ:UNIS) to provide the injectors to the partners of Sanofi under by entering into new third party tie ups. Since the announcement of the tie up the share price of Unilife has gained by nearly 36.5 percent. In yesterday’s trading the shares were up by 20.23% to close at $3.15.
Even as news reports started to make the rounds that the U.S mainland has witnessed its first death linked to the dreaded Ebola virus, the shares of Lakeland Industries, Inc. (NASDAQ:LAKE) witnessed renewed buying interest in the stock market. The company is the maker of the widely used hazmat-s body suits worn by the medical personal who provide care to the patients suspected to be suffering from Ebola virus.
Mr. Duncan passed away in Dallas yesterday. Investors had been buying into the stock of Lakeland Industries, Inc. (NASDAQ:LAKE) ever since it was officially announced last week that Ebola has arrived in U.S. The stock is up 57 percent since October 1st. Shares of Lakeland Industries, Inc. (NASDAQ:LAKE) were up by 15.85% to close at $11.62.
Bio-pharmaceutical firm Radius Health Inc (NASDAQ:RDUS) shares rose sharply during trading on 8th October after the drug firm announced that it has successfully closed the public offering of nearly 3.128 million shares. It had raised close to $53.3 million from the exercise. It hopes to use the funds generated to fund its R&D efforts. Shares of the company surged by 13.87% to close at $23.31.